BIZARRE: 2 | Mind Blowing Facts

Tragedy of British Army veteran haunted by serving in Iraq and Afghanistan found dead at home

Ben Riches was just 30 when he passed away

Manchester Evening News · Nov 9, 2022

Terrified mum-of-four suffers flashbacks after being put on Covid ventilator while heavily pregnant

Mechelle Smith insists doctors saved her and her son after she became seriously unwell.

Daily Record · Aug 31, 2022

DST’s decision to scrap KVPY disappoints teachers, aspirants in government schools

The decision of Department of Science and Technology, New Delhi, to scrap Kishore Vaigyanik Protsahan Yojna (KVPY) fellowship from this year has caused disappointment among school teachers who were keenly anticipating its conduct in Tamil for the convenience of the students following the Supreme Court's intervention last year.

The Hindu · Jul 27, 2022

Zynerba Pharmaceuticals Reveals Positive Results From Phase 2 INSPIRE Trial Of Zygel In 22q11.2 Deletion Syndrome

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) revealed positive top line results from the exploratory, open label Phase 2 INSPIRE trial. Based on the positive Phase 2 data, the company will request a meeting with the U.S.

Benzinga · Jun 22, 2022

Capricor Shares Fall After Topline Results From Mid-Stage COVID-19 Trial

Capricor Therapeutics Inc (NASDAQ: CAPR) announced topline data from its Phase 2 INSPIRE study evaluating a single-dose intravenous infusion of CAP-1002 for hospitalized COVID-19 patients.

Benzinga · Mar 28, 2022

Maharashtra: Public bench, Parkinson’s device win science award

PUNE: A rolling shutter-type public bench, a tremor profiling device for patients of Parkinson’s, a broom or brush cleaner are among 31 projects by students that won this year’s state Inspire awards under the department of science and technology. Six of these projects are from Pune district.

The Times of India · Mar 24, 2022

Zynerba Pharmaceuticals Reveals Lower Net Loss For Q4 And Full Year 2021

Manufacturer of transdermal cannabinoid therapies for neuropsychiatric disorders, Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) reported Tuesday financial results for the fourth quarter and full year ended December 31, 2021.

Benzinga · Mar 1, 2022

Zynerba Pharmaceuticals Completes Enrollment For CBD Transdermal Trial For 22q Deletion Syndrome

Manufacturer of transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, Zynerba Pharmaceuticals, Inc.

Benzinga · Feb 28, 2022

Real-World Analysis Show Takeda's Alofisel Clinical Remission Rate At Six-Months

Takeda Pharmaceutical Co Ltd (NYSE: TAK) announced the first six-month interim analysis results from INSPIRE study evaluating the Real-World Effectiveness and Safety of Alofisel (darvadstrocel).

Benzinga · Feb 18, 2022

INSPIRESat-1 satellite healthy: IIST

It would study ionosphere dynamics and sun's coronal heating processes

The Hindu · Feb 14, 2022